Pharmbio Korea   Report issue

For profit Phase 1 Phase 3 Phase 4
Founded: Seoul Korea, Republic of (1999)
Status: No NME R&D (1999)

Organization Overview

First Clinical Trial
2011
NCT01373021
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Pharmbio Korea | Pharmbio Korea Co., Ltd.